Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 03 Apr 2024 for Ventyx Biosciences, Inc., €7,050. Read the official filing
Filing timeline
BuySaleMartin Auster
Insider track record
Disclosed buys
0
Disclosed sells
3
Signal history
Martin Auster: trading record in brief
All filings by Martin Auster on record concern Ventyx Biosciences, Inc. Between 2 December 2022 and 2 April 2024, the trades on record add up to 10 filings.
No open-market purchase appears, only 3 sales worth €3.2M. Outside the open market, there are 7 option exercises. In 2024 alone, the filings show no purchases and 1 sale.
On 3 April 2024 came the latest disclosure, an open-market sale for €7,050 in Ventyx Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Martin Auster
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
1,405 shares@ US$5.40350.2% of flowCommon StockSEC:0001415889-24-010177:0
4,531 shares0Common StockSEC:0001415889-24-009456:0
18,327 shares@ US$32.257514.6% of flowCommon StockSEC:0001209191-23-048632:0
28,000 shares@ US$3.452.3% of flowCommon StockSEC:0001209191-23-043460:0
28,000 shares@ US$3.452.4% of flowCommon StockSEC:0001209191-23-035224:0
28,000 shares@ US$3.452.3% of flowCommon StockSEC:0001209191-23-025876:0
7,000 shares@ US$3.450.6% of flowCommon StockSEC:0001209191-23-024854:0
21,000 shares@ US$3.451.8% of flowCommon StockSEC:0001209191-23-023474:0
97,647 shares@ US$29.008671.4% of flowCommon StockSEC:0000899243-22-037793:1
50,000 shares@ US$3.454.4% of flowCommon StockSEC:0000899243-22-037793:0
10 of 10 declarations
